We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Combination of mangiferin and T0901317 targeting autophagy promotes cholesterol efflux from macrophage foam cell in atherosclerosis

    Background

    The synthetic liver X receptor ligand (LXR) T0901317 (T0) has been reported to attenuate atherosclerosis (AS) without hyperglyceridemia due...

    Qian Chen, Sijian Wang, ... Tao Wang in Chinese Medicine
    Article Open access 05 January 2024
  2. Danlou Recipe promotes cholesterol efflux in macrophages RAW264.7 and reverses cholesterol transport in mice with hyperlipidemia induced by P407

    Introduction

    Liver X Receptor (LXR) agonists could attenuate the development of atherosclerosis but bring excess lipid accumulation in the liver....

    Wenrun Han, Dandan Zhang, ... Yan Zhu in BMC Complementary Medicine and Therapies
    Article Open access 08 December 2023
  3. Extracts from Argentinian native plants reverse fluconazole resistance in Candida species by inhibiting the efflux transporters Mdr1 and Cdr1

    Background

    The development of multidrug resistance (MDR) associated with the overexpression of the efflux transporters Mdr1 and Cdr1 in Candida ...

    Florimar Gil, Jerónimo Laiolo, ... María Cecilia Carpinella in BMC Complementary Medicine and Therapies
    Article Open access 12 October 2022
  4. Behaviorally penetrant, anomalous dopamine efflux exposes sex and circuit dependent regulation of dopamine transporters

    Virtually all neuropsychiatric disorders display sex differences in prevalence, age of onset, and/or clinical symptomology. Although altered dopamine...

    Adele Stewart, Felix P. Mayer, ... Randy D. Blakely in Molecular Psychiatry
    Article 18 September 2022
  5. Luteolin increases susceptibility to macrolides by inhibiting MsrA efflux pump in Trueperella pyogenes

    Trueperella pyogenes ( T. pyogenes ) is an opportunistic pathogen associated with a variety of diseases in many domestic animals. Therapeutic treatment...

    Yuru Guo, Chengcheng Huang, ... Mingchun Liu in Veterinary Research
    Article Open access 10 January 2022
  6. HDL functionality in type 1 diabetes: enhancement of cholesterol efflux capacity in relationship with decreased HDL carbamylation after improvement of glycemic control

    Background

    Reduced cholesterol efflux capacity (CEC) of HDLs is likely to increase cardiovascular risk in type 1 diabetes (T1D). We aimed to assess...

    Damien Denimal, Serge Monier, ... Benjamin Bouillet in Cardiovascular Diabetology
    Article Open access 12 August 2022
  7. MicroRNA-33-5p inhibits cholesterol efflux in vascular endothelial cells by regulating citrate synthase and ATP-binding cassette transporter A1

    Background

    A high level of total cholesterol is associated with several lipid metabolism disorders, including atherosclerosis and cardiovascular...

    Qiong **e, Jianqiang Peng, ... Feng Li in BMC Cardiovascular Disorders
    Article Open access 13 September 2021
  8. Strategies to Combat Bacterial Antimicrobial Resistance: a Focus on Mechanism of the Efflux Pumps Inhibitors

    The surge in multidrug resistance (MDR) in the bacterial system has constricted the use of foregoing therapeutics for the treatment of fatal...

    Privita Verma, Monalisa Tiwari, Vishvanath Tiwari in SN Comprehensive Clinical Medicine
    Article 05 February 2021
  9. Inhibition of the uric acid efflux transporter ABCG2 enhances stimulating effect of soluble uric acid on IL-1β production in murine macrophage-like J774.1 cells

    Soluble uric acid (UA) absorbed by cells through UA transporters (UATs) accumulates intracellularly, activates the NLRP3 inflammasome and thereby...

    Tomomi Notsu, Yasutaka Kurata, ... Ichiro Hisatome in Hypertension Research
    Article 17 August 2023
  10. Insulin Rescued MCP-1-Suppressed Cholesterol Efflux to Large HDL2 Particles via ABCA1, ABCG1, SR-BI and PI3K/Akt Activation in Adipocytes

    Purpose

    Intracellular cholesterol imbalance plays an important role in adipocyte dysfunction of obesity. However, it is unclear whether obesity...

    Runlu Sun, Pu Fang, ... Yuling Zhang in Cardiovascular Drugs and Therapy
    Article Open access 19 March 2021
  11. Comparative analysis of carbapenemases, RND family efflux pumps and biofilm formation potential among Acinetobacter baumannii strains with different carbapenem susceptibility

    Aim

    This study has conducted a comparative analysis of common carbapenemases harboring, the expression of resistance-nodulation-cell division (RND)...

    Yanpeng Zhang, Bing Fan, ... Dayong Gu in BMC Infectious Diseases
    Article Open access 20 August 2021
  12. The influence of verapamil on the pharmacokinetics of the pan-HER tyrosine kinase inhibitor neratinib in rats: the role of P-glycoprotein-mediated efflux

    Neratinib, an irreversible pan-HER tyrosine kinase inhibitor, has been approved for the treatment of HER2-positive (HER2 + ) early-stage and brain...

    Defei Qi, Yuanyuan Dou, ... Hua Sun in Investigational New Drugs
    Article 04 November 2022
  13. The influence of high-density lipoprotein (HDL) and HDL subfractions on insulin secretion and cholesterol efflux in pancreatic derived β-cells

    Background

    High-density lipoprotein (HDL) is considered a complex plasma-circulating particle with subfractions that vary in function, size, and...

    A. Ochoa-Guzmán, D. Guillén-Quintero, ... M. T. Tusié-Luna in Journal of Endocrinological Investigation
    Article 24 January 2021
  14. Bioactive constituents with antibacterial, resistance modulation, anti-biofilm formation and efflux pump inhibition properties from Aidia genipiflora stem bark

    Background

    Antimicrobial resistance is a global health challenge. The involvement of bacterial biofilms and efflux pumps in the development of...

    Daniel Anokwah, Evelyn Asante-Kwatia, ... Lukas Oberer in Clinical Phytoscience
    Article Open access 05 March 2021
  15. HDL cholesterol efflux capacity and lipid profile in patients with systemic sclerosis

    Objective

    It is well established that patients with systemic sclerosis (SSc) have a disrupted lipid profile and an increased cardiovascular risk....

    Iván Ferraz-Amaro, Esmeralda Delgado-Frías, ... Federico Diaz-González in Arthritis Research & Therapy
    Article Open access 23 February 2021
  16. The TonB system in Aeromonas hydrophila NJ-35 is essential for MacA2B2 efflux pump-mediated macrolide resistance

    The TonB system is generally considered as an energy transporting device for the absorption of nutrients. Our recent study showed that deletion of...

    Yuhao Dong, Qing Li, ... Yongjie Liu in Veterinary Research
    Article Open access 29 April 2021
  17. Improvements in cholesterol efflux capacity of HDL and adiponectin contribute to mitigation in cardiovascular disease risk after bariatric surgery in a cohort with morbid obesity

    Background

    Bariatric surgery can alleviate cardiovascular risk via effects on cardiovascular disease (CVD) risk factors such as diabetes mellitus,...

    Himani Thakkar, Vinnyfred Vincent, ... Archna Singh in Diabetology & Metabolic Syndrome
    Article Open access 17 April 2021
  18. Molecular and phenotypic characterization of efflux pump and biofilm in multi-drug resistant non-typhoidal Salmonella Serovars isolated from food animals and handlers in Lagos Nigeria

    Background

    Multidrug resistance efflux pumps and biofilm formation are mechanisms by which bacteria can evade the actions of many antimicrobials....

    Elizabeth Tolulope Olubisose, Abraham Ajayi, ... Stella Ifeanyi Smith in One Health Outlook
    Article Open access 09 February 2021
  19. Association between cholesterol efflux capacity and peripheral artery disease in coronary heart disease patients with and without type 2 diabetes: from the CORDIOPREV study

    Background

    Peripheral artery disease (PAD) is recognized as a significant predictor of mortality and adverse cardiovascular outcomes in patients with...

    Elena M. Yubero-Serrano, Juan F. Alcalá-Diaz, ... Jose Lopez-Miranda in Cardiovascular Diabetology
    Article Open access 25 March 2021
Did you find what you were looking for? Share feedback.